Benzinga · May 14, 2026
Galera Therapeutics Q1 EPS $(0.01), Same YoY
Galera Therapeutics (NASDAQ:GRTX) reported quarterly losses of $(0.01) per share. This is unchanged from the same period last year.
GR
OTC · GRTX
Galera Therapeutics, Inc.
Healthcare · Biotechnology
$17.15
Up+$1.53 (+9.80%)
Updated Oct 10, 2026, 8:04 AM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.81M
- P/E ratio
- -0.18
- Dividend yield
- 0.00%
- 52-week range
- $0.02 – $0.06
- Volume
- 65.01K
- Avg. volume
- 125.56K
Price performance · GRTX
GRTX price history
1M range · 0 trading sessions · Daily adjusted prices
GRTX does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest GRTX news
The latest Smart Investors Daily articles mentioning GRTX.
Stock researchCompany · Overview
Company
Market Activity
Research & News
GRTX research
Overview
Company profile and research snapshot.
Company profile
GALERA THERAPEUTICS INC
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 29, 2023 | Citigroup | Neutral | — |
| Aug 16, 2023 | HC Wainwright & Co. | Neutral | — |
| Aug 10, 2023 | Piper Sandler | Neutral | — |
| Jul 17, 2023 | HC Wainwright & Co. | Buy | — |
| Mar 22, 2023 | HC Wainwright & Co. | Buy | — |
News briefing
No generated briefing is available yet.
Finnhub · Apr 14, 2026
Obsidian Therapeutics, Inc. agreed to acquire Galera Therapeutics, Inc. in a reverse merger transaction.
Obsidian Therapeutics, Inc. agreed to acquire Galera Therapeutics, Inc. in a reverse merger transaction on April 14, 2026. Upon completion of the transaction, the combined company plans to operate...
Finnhub · Apr 14, 2026
GRTX Stock Alert: Halper Sadeh LLC is Investigating Whether Galera Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.The proposed transaction may contain terms that could limit superior competing offers.Shareholders...
Finnhub · Apr 14, 2026
Galera Therapeutics and Obsidian Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement
Combined company to operate as Obsidian Therapeutics, Inc. and to advance Obsidian’s pipeline of novel engineered TIL cell therapies for the treatment of patients with solid tumors.Obsidian’s lead...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
